Cargando…

Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems

INTRODUCTION: Every year about 83,000 women are diagnosed with cervical cancer in the Americas. Latin America and the Caribbean (LAC) has one of the highest incidence and mortality rates from cervical cancer in the world. Although incidence has decreased by half in the last 30 years, cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Santamaría-Ulloa, Carolina, Quirós-Rojas, Ileana, Montero-López, Melina, Quesada-Leitón, Hazel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239285/
https://www.ncbi.nlm.nih.gov/pubmed/34211837
http://dx.doi.org/10.3389/fonc.2021.642841
_version_ 1783715044451680256
author Santamaría-Ulloa, Carolina
Quirós-Rojas, Ileana
Montero-López, Melina
Quesada-Leitón, Hazel
author_facet Santamaría-Ulloa, Carolina
Quirós-Rojas, Ileana
Montero-López, Melina
Quesada-Leitón, Hazel
author_sort Santamaría-Ulloa, Carolina
collection PubMed
description INTRODUCTION: Every year about 83,000 women are diagnosed with cervical cancer in the Americas. Latin America and the Caribbean (LAC) has one of the highest incidence and mortality rates from cervical cancer in the world. Although incidence has decreased by half in the last 30 years, cervical cancer remains a public health concern. The detection of precursor lesions through Papanicolaou (Pap) smear remains a critical tool in the context of prevention in Costa Rica and many other LAC countries. OBJECTIVE: To determine predictors of participation in Pap smear screening among Costa Rican women, with a special focus on women who have never had a Pap smear or have had a smear 5 or more years ago. METHODS: The data source for this study is the Costa Rican Households National Survey conducted in 2014. This survey is representative at the national, urban/rural zone, and administrative region level. A subsample of women aged 20 to 69 years who responded to the survey’s Papanicolaou Module were included in this study (n = 11,709). Statistical analyses were conducted in R-Studio. Statistical significance level was set at 5%. Two multinomial regression models were estimated. The first model aimed to explain the five different categories of cytology use, which were defined according to the last time women had a Pap smear. The second model aimed to explain the five different categories of reasons why women had never had a Pap smear. Both models controlled for age, educational attainment, and marital status. RESULTS: Young women with high educational attainment were more likely to have never had a cytology. Women with a lower educational attainment, married, or in domestic relationship and of older age had greater odds of having had a cytology 5 or more years ago. Each year increment in age was significantly associated with an increase in the odds of never having a Pap smear because of health care access issues or because of cultural reasons as compared to not having an active sexual life. CONCLUSIONS: Findings can inform public policy targeted to higher risk female populations where access to health services can be improved.
format Online
Article
Text
id pubmed-8239285
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82392852021-06-30 Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems Santamaría-Ulloa, Carolina Quirós-Rojas, Ileana Montero-López, Melina Quesada-Leitón, Hazel Front Oncol Oncology INTRODUCTION: Every year about 83,000 women are diagnosed with cervical cancer in the Americas. Latin America and the Caribbean (LAC) has one of the highest incidence and mortality rates from cervical cancer in the world. Although incidence has decreased by half in the last 30 years, cervical cancer remains a public health concern. The detection of precursor lesions through Papanicolaou (Pap) smear remains a critical tool in the context of prevention in Costa Rica and many other LAC countries. OBJECTIVE: To determine predictors of participation in Pap smear screening among Costa Rican women, with a special focus on women who have never had a Pap smear or have had a smear 5 or more years ago. METHODS: The data source for this study is the Costa Rican Households National Survey conducted in 2014. This survey is representative at the national, urban/rural zone, and administrative region level. A subsample of women aged 20 to 69 years who responded to the survey’s Papanicolaou Module were included in this study (n = 11,709). Statistical analyses were conducted in R-Studio. Statistical significance level was set at 5%. Two multinomial regression models were estimated. The first model aimed to explain the five different categories of cytology use, which were defined according to the last time women had a Pap smear. The second model aimed to explain the five different categories of reasons why women had never had a Pap smear. Both models controlled for age, educational attainment, and marital status. RESULTS: Young women with high educational attainment were more likely to have never had a cytology. Women with a lower educational attainment, married, or in domestic relationship and of older age had greater odds of having had a cytology 5 or more years ago. Each year increment in age was significantly associated with an increase in the odds of never having a Pap smear because of health care access issues or because of cultural reasons as compared to not having an active sexual life. CONCLUSIONS: Findings can inform public policy targeted to higher risk female populations where access to health services can be improved. Frontiers Media S.A. 2021-06-15 /pmc/articles/PMC8239285/ /pubmed/34211837 http://dx.doi.org/10.3389/fonc.2021.642841 Text en Copyright © 2021 Santamaría-Ulloa, Quirós-Rojas, Montero-López and Quesada-Leitón https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Santamaría-Ulloa, Carolina
Quirós-Rojas, Ileana
Montero-López, Melina
Quesada-Leitón, Hazel
Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_full Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_fullStr Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_full_unstemmed Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_short Women’s Participation in Pap Smear Screening in a Developing Country: Evidence for Improving Health Systems
title_sort women’s participation in pap smear screening in a developing country: evidence for improving health systems
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239285/
https://www.ncbi.nlm.nih.gov/pubmed/34211837
http://dx.doi.org/10.3389/fonc.2021.642841
work_keys_str_mv AT santamariaulloacarolina womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems
AT quirosrojasileana womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems
AT monterolopezmelina womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems
AT quesadaleitonhazel womensparticipationinpapsmearscreeninginadevelopingcountryevidenceforimprovinghealthsystems